https://wikimd.org/index.php?action=history&feed=atom&title=Hyper-CVAD
Hyper-CVAD - Revision history
2026-05-11T21:54:06Z
Revision history for this page on the wiki
MediaWiki 1.44.2
https://wikimd.org/index.php?title=Hyper-CVAD&diff=6509231&oldid=prev
Prab: CSV import
2025-03-17T14:15:04Z
<p>CSV import</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 14:15, 17 March 2025</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l55">Line 55:</td>
<td colspan="2" class="diff-lineno">Line 55:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Oncology]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Oncology]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{No image}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{No image}}</div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">__NOINDEX__</ins></div></td></tr>
</table>
Prab
https://wikimd.org/index.php?title=Hyper-CVAD&diff=6260333&oldid=prev
Prab: CSV import
2025-02-10T21:45:03Z
<p>CSV import</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 21:45, 10 February 2025</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l54">Line 54:</td>
<td colspan="2" class="diff-lineno">Line 54:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Chemotherapy regimens]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Chemotherapy regimens]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Oncology]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Oncology]]</div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{No image}}</ins></div></td></tr>
</table>
Prab
https://wikimd.org/index.php?title=Hyper-CVAD&diff=6025373&oldid=prev
Prab: CSV import
2024-12-03T11:32:17Z
<p>CSV import</p>
<p><b>New page</b></p><div>Hyper-CVAD<br />
<br />
Hyper-CVAD is an intensive chemotherapy regimen used primarily in the treatment of certain types of leukemia and lymphoma. The regimen is known for its alternating cycles of chemotherapy drugs, which are designed to target rapidly dividing cancer cells. This article provides a comprehensive overview of the Hyper-CVAD regimen, its components, indications, administration, and potential side effects.<br />
<br />
==Components of Hyper-CVAD==<br />
The Hyper-CVAD regimen consists of two alternating courses, referred to as Course A and Course B. Each course includes a combination of chemotherapy drugs:<br />
<br />
===Course A===<br />
* '''Cyclophosphamide''': An alkylating agent that interferes with the replication of DNA, thereby inhibiting cancer cell growth.<br />
* '''Vincristine''': A vinca alkaloid that disrupts microtubule formation, preventing cell division.<br />
* '''Doxorubicin (Adriamycin)''': An anthracycline antibiotic that intercalates DNA, inhibiting topoisomerase II and generating free radicals.<br />
* '''Dexamethasone''': A corticosteroid that helps reduce inflammation and can induce apoptosis in certain cancer cells.<br />
<br />
===Course B===<br />
* '''Methotrexate''': An antimetabolite that inhibits dihydrofolate reductase, leading to reduced DNA synthesis.<br />
* '''Cytarabine (Ara-C)''': A pyrimidine analog that inhibits DNA polymerase, preventing DNA replication.<br />
<br />
==Indications==<br />
Hyper-CVAD is primarily used in the treatment of:<br />
* [[Acute Lymphoblastic Leukemia (ALL)]]<br />
* [[Non-Hodgkin Lymphoma]]<br />
* [[Burkitt's Lymphoma]]<br />
* [[Mantle Cell Lymphoma]]<br />
<br />
==Administration==<br />
The Hyper-CVAD regimen is typically administered in a hospital setting due to its intensity and the need for close monitoring. Each cycle of Hyper-CVAD consists of:<br />
* '''Course A''': Administered over 3-4 days, followed by a recovery period.<br />
* '''Course B''': Administered over 3-4 days, following the recovery period from Course A.<br />
<br />
Patients usually receive supportive care, including growth factors, antibiotics, and transfusions, to manage side effects and maintain blood counts.<br />
<br />
==Side Effects==<br />
Common side effects of the Hyper-CVAD regimen include:<br />
* Myelosuppression (leading to anemia, neutropenia, and thrombocytopenia)<br />
* Nausea and vomiting<br />
* Mucositis<br />
* Alopecia<br />
* Fatigue<br />
* Risk of infection due to immunosuppression<br />
<br />
==Prognosis and Outcomes==<br />
The effectiveness of Hyper-CVAD varies depending on the type and stage of cancer, as well as patient-specific factors. It is considered a highly effective regimen for certain aggressive lymphomas and leukemias, often leading to remission.<br />
<br />
==Also see==<br />
* [[Chemotherapy]]<br />
* [[Leukemia]]<br />
* [[Lymphoma]]<br />
* [[Bone Marrow Transplant]]<br />
* [[Oncology]]<br />
<br />
{{Chemotherapy regimens}}<br />
{{Oncology}}<br />
<br />
[[Category:Chemotherapy regimens]]<br />
[[Category:Oncology]]</div>
Prab